How long is long enough? An international survey exploring practice variations on the recommended duration of maintenance therapy with PARP inhibitors in patients with platinum sensitive recurrent ovarian cancer and long-term outcomes.

MLA

Haggstrom, Lucy, et al. “How Long Is Long Enough? An International Survey Exploring Practice Variations on the Recommended Duration of Maintenance Therapy with PARP Inhibitors in Patients with Platinum Sensitive Recurrent Ovarian Cancer and Long-Term Outcomes.” International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society, vol. 34, no. 12, Dec. 2024, pp. 1932–39. EBSCOhost, https://doi.org/10.1136/ijgc-2024-005976.

APA

Haggstrom, L., Lee, Y. C., Scott, C., Harter, P., Woelber, L., Ledermann, J., Gourley, C., McNeish, I. A., Amant, F., Ray-Coquard, I., Leary, A., Oza, A. M., Tinker, A., González Martin, A., Cecere, S. C., Pignata, S., Colombo, N., Yoshida, H., Marth, C., … Friedlander, M. L. (2024). How long is long enough? An international survey exploring practice variations on the recommended duration of maintenance therapy with PARP inhibitors in patients with platinum sensitive recurrent ovarian cancer and long-term outcomes. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society, 34(12), 1932–1939. https://doi.org/10.1136/ijgc-2024-005976

Chicago

Haggstrom, Lucy, Yeh Chen Lee, Clare Scott, Philipp Harter, Linn Woelber, Jonathan Ledermann, Charlie Gourley, et al. 2024. “How Long Is Long Enough? An International Survey Exploring Practice Variations on the Recommended Duration of Maintenance Therapy with PARP Inhibitors in Patients with Platinum Sensitive Recurrent Ovarian Cancer and Long-Term Outcomes.” International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society 34 (12): 1932–39. doi:10.1136/ijgc-2024-005976.